Pharmaceutical companies by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Takeda Pharmaceutical has the lowest figure of the 61 pharmaceutical companies ranked by short interest, at 0.10%, followed by AstraZeneca (0.20%) and Novartis (0.24%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- Takeda Pharmaceutical0.10%
- Median
- 5.47%
- Combined market value
- NOK 49.09T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Short interest % ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Takeda PharmaceuticalTAK · Health Care | 0.10% | NOK 659.5B | NOK 206.43 | 1.66% down | 54% up | ||
| 2 | AstraZenecaAZN · Health Care | 0.20% | NOK 2.69T | NOK 1,731.78 | 2.06% down | 2% up | ||
| 3 | NovartisNVS · Health Care | 0.24% | NOK 2.84T | NOK 1,504.39 | 2.55% down | 25% up | ||
| 4 | SanofiSNY · Health Care | 0.51% | NOK 1.1T | NOK 457.83 | 0.70% down | 4% down | ||
| 5 | Johnson & JohnsonJNJ · Health Care | 0.71% | NOK 6.39T | NOK 2,653.45 | 1.86% down | 38% up | ||
| 6 | GSKGSK · Health Care | 0.81% | NOK 945.1B | NOK 471.50 | 1.29% down | 6% up | ||
| 7 | Eli LillyLLY · Health Care | 0.81% | NOK 11.96T | NOK 13,424.24 | 2.24% down | 35% up | ||
| 8 | Novo NordiskNVO · Health Care | 0.87% | NOK 1.68T | NOK 382.26 | 3.18% down | 17% down | ||
| 9 | GrifolsGRFS · Health Care | 0.88% | NOK 55.6B | NOK 81.69 | 2.42% down | 1% up | ||
| 10 | AbbVieABBV · Health Care | 0.89% | NOK 4.9T | NOK 2,770.29 | 2.47% down | 26% up | ||
| 11 | Merck & CoMRK · Health Care | 1.08% | NOK 3.28T | NOK 1,332.06 | 4.22% down | 51% up | ||
| 12 | Abbott LaboratoriesABT · Health Care | 1.10% | NOK 1.76T | NOK 1,013.83 | 0.19% down | 17% down | ||
| 13 | BeOne MedicinesONC · Health Care | 1.40% | NOK 447.8B | NOK 3,920.56 | 2.20% down | 17% up | ||
| 14 | GenmabGMAB · Health Care | 1.57% | NOK 306.8B | NOK 497.55 | 1.29% down | 70% up | ||
| 15 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | NOK 1.32T | NOK 5,214.44 | 0.62% up | 27% up | ||
| 16 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | NOK 948.1B | NOK 9,164.78 | 1.36% down | 36% up | ||
| 17 | Royalty PharmaRPRX · Health Care | 2.27% | NOK 386.8B | NOK 672.70 | 0.97% up | 78% up | ||
| 18 | Bristol-Myers SquibbBMY · Health Care | 2.29% | NOK 1.18T | NOK 578.07 | 2.87% down | 34% up | ||
| 19 | PfizerPFE · Health Care | 2.36% | NOK 1.55T | NOK 272.03 | 1.50% down | 14% up | ||
| 20 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.38% | NOK 476.9B | NOK 408.69 | 1.15% down | 74% up | ||
| 21 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.03% | NOK 121.2B | NOK 145.37 | 1.32% up | 5% up | ||
| 22 | ViatrisVTRS · Health Care | 3.07% | NOK 228.9B | NOK 199.69 | 0.66% up | 96% up | ||
| 23 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | NOK 73.7B | NOK 211.57 | 3.27% up | 83% up | ||
| 24 | Belite BioBLTE · Health Care | 3.40% | NOK 61.7B | NOK 1,520.16 | 0.64% down | 31% up | ||
| 25 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | NOK 194B | NOK 1,448.52 | 4.59% down | 66% down | ||
| 26 | ZoetisZTS · Health Care | 4.12% | NOK 336.5B | NOK 828.24 | 2.27% up | 29% down | ||
| 27 | United TherapeuticsUTHR · Health Care | 4.31% | NOK 239.2B | NOK 5,615.86 | 0.89% down | 23% up | ||
| 28 | Ascendis PharmaASND · Health Care | 4.57% | NOK 171.6B | NOK 2,616.49 | 0.54% down | 28% up | ||
| 29 | ABIVAXABVX · Health Care | 4.70% | NOK 70.9B | NOK 810.21 | 1.73% up | 27% down | ||
| 30 | Summit TherapeuticsSMMT · Health Care | 5.28% | NOK 82B | NOK 102.54 | 0.94% down | 36% down | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 5.47% | NOK 72.3B | NOK 919.92 | 0.29% down | 126% up | ||
| 32 | Legend BiotechLEGN · Health Care | 6.13% | NOK 30.4B | NOK 156.76 | 0.31% up | 42% down | ||
| 33 | Axsome TherapeuticsAXSM · Health Care | 6.20% | NOK 68.5B | NOK 1,301.94 | 1.28% down | 7% down | ||
| 34 | Roivant SciencesROIV · Health Care | 6.28% | NOK 270B | NOK 372.70 | 0.75% down | 90% up | ||
| 35 | InsmedINSM · Health Care | 6.42% | NOK 255.7B | NOK 1,165.45 | 1.41% down | 40% down | ||
| 36 | Elanco Animal HealthELAN · Health Care | 6.59% | NOK 130.2B | NOK 260.47 | 3.87% up | 20% up | ||
| 37 | Definium TherapeuticsDFTX · Health Care | 7.02% | NOK 38B | NOK 277.34 | 2.69% down | 169% up | ||
| 38 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | NOK 114.5B | NOK 591.07 | 4.14% up | 11% up | ||
| 39 | VeradermicsMANE · Health Care | 8.03% | NOK 50.9B | NOK 1,205.51 | 1.09% down | 233% up | ||
| 40 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | NOK 59.3B | NOK 419.22 | 0.52% up | 10% up | ||
| 41 | Corcept TherapeuticsCORT · Health Care | 8.34% | NOK 71.9B | NOK 656.57 | 3.41% down | 8% down | ||
| 42 | Jazz PharmaceuticalsJAZZ · Health Care | 9.03% | NOK 153B | NOK 2,384.06 | 2.10% up | 37% up | ||
| 43 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | NOK 90.5B | NOK 3,896.74 | 4.81% down | 24% down | ||
| 44 | PTC TherapeuticsPTCT · Health Care | 9.31% | NOK 48.6B | NOK 582.05 | 0.60% down | 20% down | ||
| 45 | Oruka TherapeuticsORKA · Health Care | 9.53% | NOK 62.7B | NOK 924.58 | 1.05% down | 241% up | ||
| 46 | Travere TherapeuticsTVTX · Health Care | 9.96% | NOK 47B | NOK 489.94 | 1.16% down | 44% up | ||
| 47 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | NOK 58.4B | NOK 893.92 | 0.22% up | 31% up | ||
| 48 | Cogent BiosciencesCOGT · Health Care | 10.0% | NOK 47.4B | NOK 272.49 | 0.86% up | 20% down | ||
| 49 | ErascaERAS · Health Care | 10.6% | NOK 45.8B | NOK 130.60 | 3.08% down | 403% up | ||
| 50 | BridgeBio PharmaBBIO · Health Care | 10.7% | NOK 146.8B | NOK 753.65 | 1.16% up | 17% up | ||
| 51 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | NOK 44.2B | NOK 403.26 | 1.12% down | 88% up | ||
| 52 | AlkermesALKS · Health Care | 11.7% | NOK 75.6B | NOK 449.92 | 2.05% up | 58% up | ||
| 53 | Spyre TherapeuticsSYRE · Health Care | 12.2% | NOK 91.6B | NOK 964.64 | 6.00% up | 286% up | ||
| 54 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | NOK 58.1B | NOK 2,903.14 | 1.86% up | 43% up | ||
| 55 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | NOK 44.7B | NOK 268.18 | 2.54% up | 64% down | ||
| 56 | CytokineticsCYTK · Health Care | 12.9% | NOK 69.1B | NOK 496.39 | 0.93% down | 20% down | ||
| 57 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | NOK 83.1B | NOK 2,974.01 | 0.50% up | 61% up | ||
| 58 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | NOK 79.4B | NOK 1,217.06 | 0.63% up | 46% up | ||
| 59 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | NOK 46.8B | NOK 830.29 | 1.60% down | 113% up | ||
| 60 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | NOK 80.8B | NOK 1,165.06 | 2.99% up | 13% up | ||
| 61 | TG TherapeuticsTGTX · Health Care | 19.0% | NOK 96.3B | NOK 637.00 | 4.71% up | 107% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7007 NOK).
Questions and answers
Which pharmaceutical companies have the lowest short interest?
Takeda Pharmaceutical (0.10%), AstraZeneca (0.20%) and Novartis (0.24%) have the lowest short interest of the 61 pharmaceutical companies ranked here as of the 30 Oct 2026 settlement date.
How many pharmaceutical companies are in this ranking?
61 are ranked by short interest.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by short interest have a combined market value of NOK 49.09T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Pharmaceutical companies by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.